NYSE Euronext welcomes Cryo-Save to its European Market

Amsterdam, 22 October 2009 – Dutch-based leading European stem cell storage bank, Cryo-Save Group N.V. (NYSE Euronext: CRYO) completed its listing on NYSE Euronext Amsterdam today.

Cryo-Save has storage and processing facilities in 5 countries and is operating in 38 countries in Europe, Asia and Africa. With over 115.000 samples stored, Cryo-Save is Europe’s largest adult stem cell storage bank. Cryo-Save shares trade on NYSE Euronext under the symbol 'CRYO' and are denominated in Euros. After opening, the first market price was €6.30 per share. Based on the total number of 9,639,191 shares the total market capitalization of the company at opening price was €60,726,903.

Attachments Available Languages
NYSE Euronext Welcomes Cryo-Save to its European Marketen

About Euronext
Euronext is the leading pan-European exchange in the Eurozone, covering Belgium, France, Ireland, The Netherlands, Portugal and the UK. With 1,300 listed issuers worth €3.4 trillion in market capitalisation as of end December 2018, Euronext is an unmatched blue chip franchise that has 24 issuers in the Morningstar® Eurozone 50 Index℠ and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext GrowthTM and Euronext AccessTM, simplifying access to listing for SMEs. 
For the latest news, find us on Twitter  (www.twitter.com/euronext) and LinkedIn (www.linkedin.com/company/euronext).

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2019, Euronext N.V. - All rights reserved.